Sudeep Pharma Limited announced that its Board of Directors, during a meeting held on October 28, 2026, has reviewed and approved the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The board meeting commenced at 03:10 p.m. and concluded at 04:25 p.m. The company has requested this information be taken on record.
Board Meeting Outcomes
Sudeep Pharma Limited convened its Board of Directors meeting on Wednesday, October 28, 2026. During this meeting, the Board transacted key business, most notably considering and approving the unaudited standalone and consolidated financial results for the quarter and half-year period that concluded on September 30, 2026.
Meeting Details
The Board meeting commenced at 03:10 p.m. and concluded its deliberations at 04:25 p.m. on the same day. The company has formally requested that this information be recorded.
Financial Reporting
The approved financial results cover the performance for the quarter and the year-to-date period ending September 30, 2026. These results have undergone a limited review by the statutory auditors, BSR and Co, Chartered Accountants, as detailed in their report.
Source: BSE
